Funded Tech Companies
Sorriso Pharmaceuticals
Sorriso Pharmaceuticals, operating out of San Diego, received equity investments through New Enterprise Associates, Arix Bioscience and private investors.
Company Overview
Company Name
Sorriso Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Company Background Information
Overview
Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of inflammatory disease, including Crohn's disease and ulcerative colitis. The Sorriso platform generates potent antibodies that can be delivered orally and are designed to maintain activity throughout the intestinal system.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/23/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ciara Kennedy
Company Investors
- New Enterprise Associates (Ed Mathers)
- Arix Bioscience (Mark Chin)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs